Join our community of traders FOR FREE!

  • Learn
  • Improve yourself
  • Get Rewards
Learn More

During yesterday’s trading session NZD/USD traded within the range of 0.8420-0.8488 and closed at 0.8479, gaining 0.64% on a daily basis.

At 9:23 GMT today NZD/USD was adding 0.46% for the day to trade at 0.8497. The pair touched a daily high at 0.8501 at 8:34 GMT, the pairs highest since August 5th.

Fundamental view

Initial jobless claims in the US probably rose to 307 000 in the week ended August 9th, from 289 000 a week ago, according to the median estimate by experts.

The indicator measures the number of applications for unemployment benefits that are recorded each week in a report prepared by the Bureau of Labor Statistics in the United States. Initial application or (Initial Claim) means a completed document from an unemployed person before the local government, which is considered a claim for compensation or the possibility of compensation. The completion of the initial claim marks the beginning of a period in which the applicant receives unemployment benefits. The survey covers the number of applications registered in the previous week and is an important indicator concerning the health of the US labor market.

The statistical arm of the US Department of Labor will release an official report at 12:30 GMT today. If jobless claims rose less than expected, this will provide support for the US dollar.

Technical view

Screenshot from 2014-08-14 12:28:15

According to Binary Tribune’s daily analysis, the central pivot point for the pair is at 0.8462. In case NZD/USD manages to breach the first resistance level at 0.8505, it will probably continue up to test 0.8530. In case the second key resistance is broken, the pair will probably attempt to advance to 0.8573.

If NZD/USD manages to breach the first key support at 0.8437, it will probably continue to slide and test 0.8394. With this second key support broken, the movement to the downside will probably continue to 0.8369.

In weekly terms, the central pivot point is at 0.8472. The three key resistance levels are as follows: R1 – 0.8521, R2 – 0.8579, R3 – 0.8628. The three key support levels are: S1 – 0.8414, S2 – 0.8365, S3 – 0.8307.

TradingPedia.com is a financial media specialized in providing daily news and education covering Forex, equities and commodities. Our academies for traders cover Forex, Price Action and Social Trading.

Related News

  • Copper rebounds after plunging on negative China PMI dataCopper rebounds after plunging on negative China PMI data Copper fell during Asian and early European trading on Wednesday, followed by a rebound close to six-week highs as prices continued to draw support from Chinese governments intentions to boost economic growth and QE outlook.On the Comex […]
  • Hilton enters the largest hotel initial public offeringHilton enters the largest hotel initial public offering Although the lodging chain Hilton Worldwide Holdings Inc. was bought by Blackstone Group LP in 2007, it now plans to raise its initial public offering in the United States of America to 2.4 billion dollars, which is the highest initial public […]
  • Stocks worth followingStocks worth following Consumer Goods Cambell is the top performer in packaged food business with $5 above the consensus price of its shares. Companys estimates are believed to raise even more beginning with sales increase of 12%. Cambell is beating its […]
  • KBR awarded contract by SABIC Fujian PetrochemicalsKBR awarded contract by SABIC Fujian Petrochemicals KBR Inc (NYSE: KBR), a global technology licensor, said on Monday that it had secured a contract by SABIC Fujian Petrochemicals to license KBR's phenol technology in China.Under the terms of the agreement, KBR is to provide technology […]
  • Pfizer Inc.’s share price down, to buy rights to a cancer drug of Merck at the price of $850 millionPfizer Inc.’s share price down, to buy rights to a cancer drug of Merck at the price of $850 million Pfizer Inc. is to pay $850 million for rights to a cancer drug, developed by Merck KGaA. The deal is to grant Pfizer the opportunity to get an experimental treatment such as the one it looked for when it made its takeover bid for Astrazeneca […]
  • Natural gas futures weekly recap: March 16 – March 20Natural gas futures weekly recap: March 16 – March 20 Natural gas fell on Friday but settled the week higher as cold blasts across the north-eastern US lined up. However, sentiment remained neutral, if not skewed to the upside, as the rest of the US continues to enjoy seasonal and higher […]